A successful management with electroconvulsive therapy of neuroleptic malignant syndrome due to amisulpride

被引:0
作者
Karayagmurlu, Ali [1 ]
Karayagmurlu, Elif [2 ]
Ustundag, Mehmet Fatih [3 ]
Yazla, Ece [4 ]
机构
[1] Gaziantep Child State Hosp, Dept Child & Adolescent Psychiat, Gaziantep, Turkey
[2] Gaziantep Univ, Dept Psychiat, Fac Med, Gaziantep, Turkey
[3] Erenkoy Training & Res Hosp Psychiat & Neurol Dis, Dept Psychiat, Istanbul, Turkey
[4] Hitit Univ, Fac Med, Dept Psychiat, Corum, Turkey
来源
ELECTRONIC JOURNAL OF GENERAL MEDICINE | 2018年 / 15卷 / 03期
关键词
amisulpride; atypical antipsychotics; neuroleptic malignant syndrome; electroconvulsive therapy;
D O I
10.29333/ejgm/83617
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neuroleptic malignant syndrome is a severe complication that mainly occurs based on neuroleptic drug treatment and characterized with some autonomic symptoms, altered mental state, hyperthermia and muscle rigidity. Amisulpride is a unique atypical antipsychotic that selectively blocks D2 and D3 receptors presynaptically in the frontal cortex and atypical antipsychotics are rarely caused neuroleptic malignant syndrome (NMS). This study examine a 20-years old male with the diagnosis of acute psychotic disorder occurred amisulpride-induced NMS and successfully treated with Electroconvulsive Therapy (ECT). We decided to present that case because of the fact that there is only limited number of amisulpride-induced NMS cases reported in the literature.
引用
收藏
页数:4
相关论文
共 25 条
[1]   Neuroleptic malignant syndrome [J].
Adnet, P ;
Lestavel, P ;
Krivosic-Horber, R .
BRITISH JOURNAL OF ANAESTHESIA, 2000, 85 (01) :129-135
[2]   NEUROLEPTIC MALIGNANT SYNDROME [J].
BUCKLEY, PF ;
HUTCHINSON, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1995, 58 (03) :271-273
[3]  
CASEY DA, 1987, CONVULSIVE THER, V3, P278
[4]   Risperidone versus haloperidol in the treatment of schizophrenia: A meta-analysis comparing their efficacy and safety [J].
deOliveira, IR ;
MirandaScippa, AMA ;
deSena, EP ;
Pereira, ELA ;
Ribeiro, MG ;
deCastroeSilva, E ;
Bacaltchuk, J .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1996, 21 (05) :349-358
[5]  
Guy W, 1976, ECDEU ASSESSMENT MAN, V76, P217
[6]   Novel antipsychotics and the neuroleptic malignant syndrome: A review and critique [J].
Hasan, S ;
Buckley, P .
AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (08) :1113-1116
[7]  
ITOH H, 1977, FOLIA PSYCHIAT NEU J, V31, P565
[8]   Neuroleptic malignant syndrome and atypical antipsychotics: A brief review [J].
Khaldi, S. ;
Kornreich, C. ;
Choubani, Z. ;
Gourevitch, R. .
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2008, 34 (06) :618-624
[9]  
Kostakoglu E, 1999, TURK PSIKOL DERG, V14, P23
[10]   Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder [J].
Lerner, V ;
Libov, I ;
Kotler, M ;
Strous, RD .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2004, 28 (01) :89-98